HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,678.30
Day range
₹1,671.00 - ₹1,704.50
Year range
₹722.10 - ₹1,769.60
Market cap
478.68B INR
Avg Volume
1.35M
P/E ratio
-
Dividend yield
0.15%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 32.44B | -4.63% |
Operating expense | 16.64B | -1.97% |
Net income | 3.40B | 126.94% |
Net profit margin | 10.49 | 137.87% |
Earnings per share | 12.06 | 92.45% |
EBITDA | 6.28B | -0.20% |
Effective tax rate | 26.41% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.59B | 12.91% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 78.48B | — |
Shares outstanding | 282.15M | — |
Price to book | 6.04 | — |
Return on assets | — | — |
Return on capital | 12.95% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 3.40B | 126.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Founded
1977
Website
Employees
14,989
